Application 202810
- Type
- NDA
- Sponsor
- SUPERNUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXTELLAR XR | OXCARBAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 150MG | Yes | No |
| 002 | OXTELLAR XR | OXCARBAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 300MG | Yes | No |
| 003 | OXTELLAR XR | OXCARBAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 600MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N202810-001 | OXTELLAR XR | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 |
| N202810-002 | OXTELLAR XR | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 |
| N202810-003 | OXTELLAR XR | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N202810-001 | AB |
| N202810-002 | AB |
| N202810-003 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N202810-001 | 10220042 | 2027-04-13 | U-2501 | 2019-03-28 | |
| N202810-001 | 11166960 | 2027-04-13 | Drug product | 2021-11-24 | |
| N202810-001 | 11896599 | 2027-04-13 | Drug product | 2024-02-28 | |
| N202810-001 | 7722898 | 2027-04-13 | Drug product | 2012-11-20 | |
| N202810-001 | 7910131 | 2027-04-13 | U-2041 | 2012-11-20 | |
| N202810-001 | 8617600 | 2027-04-13 | Drug product | ||
| N202810-001 | 8821930 | 2027-04-13 | Drug product | ||
| N202810-001 | 9119791 | 2027-04-13 | U-2041 | 2015-09-11 | |
| N202810-001 | 9351975 | 2027-04-13 | Drug product | 2016-06-10 | |
| N202810-001 | 9370525 | 2027-04-13 | Drug product | 2016-06-24 | |
| N202810-001 | 9855278 | 2027-04-13 | Drug product | 2018-01-05 | |
| N202810-002 | 10220042 | 2027-04-13 | U-2501 | 2019-03-28 | |
| N202810-002 | 11166960 | 2027-04-13 | Drug product | 2021-11-24 | |
| N202810-002 | 11896599 | 2027-04-13 | Drug product | 2024-02-28 | |
| N202810-002 | 7722898 | 2027-04-13 | Drug product | ||
| N202810-002 | 7910131 | 2027-04-13 | U-2041 | ||
| N202810-002 | 8617600 | 2027-04-13 | Drug product | ||
| N202810-002 | 8821930 | 2027-04-13 | Drug product | ||
| N202810-002 | 9119791 | 2027-04-13 | U-2041 | 2015-09-11 | |
| N202810-002 | 9351975 | 2027-04-13 | Drug product | 2016-06-10 | |
| N202810-002 | 9370525 | 2027-04-13 | Drug product | 2016-06-24 | |
| N202810-002 | 9855278 | 2027-04-13 | Drug product | 2018-01-05 | |
| N202810-003 | 10220042 | 2027-04-13 | U-2501 | 2019-03-28 | |
| N202810-003 | 11166960 | 2027-04-13 | Drug product | 2021-11-24 | |
| N202810-003 | 11896599 | 2027-04-13 | Drug product | 2024-02-28 | |
| N202810-003 | 7722898 | 2027-04-13 | Drug product | ||
| N202810-003 | 7910131 | 2027-04-13 | U-2041 | ||
| N202810-003 | 8617600 | 2027-04-13 | Drug product | ||
| N202810-003 | 8821930 | 2027-04-13 | Drug product | ||
| N202810-003 | 9119791 | 2027-04-13 | U-2041 | 2015-09-11 | |
| N202810-003 | 9351975 | 2027-04-13 | Drug product | 2016-06-10 | |
| N202810-003 | 9370525 | 2027-04-13 | Drug product | 2016-06-24 | |
| N202810-003 | 9855278 | 2027-04-13 | Drug product | 2018-01-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202810-002 | OXTELLAR XR | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202810-003 | OXTELLAR XR | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2012-10-19 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202810-001 | OXTELLAR XR | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2012-10-19 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N202810-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N202810-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N202810-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N202810-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N202810-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202810-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202810-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202810-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N202810-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N202810-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N202810-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202810-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202810-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202810-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202810-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202810-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202810-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202810-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202810-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202810-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202810-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202810-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202810-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202810-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202810-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202810-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202810-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202810-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202810-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N202810-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202810-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202810-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202810-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202810-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202810-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202810-001 | AB | 1 | 301d65b070ca… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 10220042 | 2027-04-13 | U-2501 | 2019-03-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 11166960 | 2027-04-13 | Drug product | 2021-11-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 11896599 | 2027-04-13 | Drug product | 2024-02-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 7722898 | 2027-04-13 | Drug product | 2012-11-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 7910131 | 2027-04-13 | U-2041 | 2012-11-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 8617600 | 2027-04-13 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 8821930 | 2027-04-13 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 9119791 | 2027-04-13 | U-2041 | 2015-09-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 9351975 | 2027-04-13 | Drug product | 2016-06-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 9370525 | 2027-04-13 | Drug product | 2016-06-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-001 | 9855278 | 2027-04-13 | Drug product | 2018-01-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 10220042 | 2027-04-13 | U-2501 | 2019-03-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 11166960 | 2027-04-13 | Drug product | 2021-11-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 11896599 | 2027-04-13 | Drug product | 2024-02-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 7722898 | 2027-04-13 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 7910131 | 2027-04-13 | U-2041 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 8617600 | 2027-04-13 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 8821930 | 2027-04-13 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 9119791 | 2027-04-13 | U-2041 | 2015-09-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 9351975 | 2027-04-13 | Drug product | 2016-06-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 9370525 | 2027-04-13 | Drug product | 2016-06-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-002 | 9855278 | 2027-04-13 | Drug product | 2018-01-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 10220042 | 2027-04-13 | U-2501 | 2019-03-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 11166960 | 2027-04-13 | Drug product | 2021-11-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 11896599 | 2027-04-13 | Drug product | 2024-02-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 7722898 | 2027-04-13 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 7910131 | 2027-04-13 | U-2041 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 8617600 | 2027-04-13 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 8821930 | 2027-04-13 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 9119791 | 2027-04-13 | U-2041 | 2015-09-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 9351975 | 2027-04-13 | Drug product | 2016-06-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 9370525 | 2027-04-13 | Drug product | 2016-06-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N202810-003 | 9855278 | 2027-04-13 | Drug product | 2018-01-05 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | 10220042 | 2027-04-13 | U-2501 | 2019-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | 11166960 | 2027-04-13 | Drug product | 2021-11-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | 11896599 | 2027-04-13 | Drug product | 2024-02-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | 7722898 | 2027-04-13 | Drug product | 2012-11-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | 7910131 | 2027-04-13 | U-2041 | 2012-11-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | 8617600 | 2027-04-13 | Drug product | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N202810-001 | 8821930 | 2027-04-13 | Drug product | caaa826d4ba7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxcarbazepine | OXCARBAZEPINE | Zameer Pharmaceuticals LLC | 8841174a-9f4b-424f-a50d-01478f2aeb29 | 2026-08-26 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Cardinal Health 107, LLC | 4ebcb0e5-1c93-4b3f-8749-6835c56afce5 | 2026-08-12 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | a2032bcc-2da5-45e5-aa3f-ddbf50909df8 | 2026-08-05 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | a90cd1f1-5258-4b0e-92fd-c4cebe47772b | 2026-08-04 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | ffc8d10c-0049-4fe5-beb8-79cc6a197ede | 2026-07-23 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | b571ee0f-3c2a-4c55-9c2b-e00014e2ec7a | 2026-07-21 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Cardinal Health 107, LLC | 3e0f8d9f-7659-4524-8f93-6200314356c8 | 2026-07-21 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | ANI Pharmaceuticals, Inc. | 867eaf99-3e31-4f75-bfae-2898804d956d | 2026-07-13 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 85a9bdee-4d10-4097-ae3d-0bf8d844a11b | 2026-07-08 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | American Health Packaging | c0f9df3f-280e-4394-8d7e-ad04803b2635 | 2026-07-02 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Major Pharmaceuticals | b1d54def-057d-4608-bc8f-1d967ac3ec91 | 2026-06-15 | Warnings, Adverse reactions | OXCARBAZEPINE |
| oxcarbazepine | OXCARBAZEPINE | Zydus Lifesciences Limited | e23d8a74-b47b-462a-b09c-90bdd58a032e | 2026-06-13 | Warnings, Adverse reactions | OXCARBAZEPINE |
| oxcarbazepine | OXCARBAZEPINE | Zydus Pharmaceuticals (USA) Inc. | 5048dc87-2d89-434d-be51-4a97b0ce0601 | 2026-06-13 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | c7718f8b-63e2-40b9-b519-e687cfc2cacf | 2026-06-11 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | 188a48ad-c412-416a-b15b-de5f232740a2 | 2026-06-11 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | 0abe9478-4084-286d-e063-6294a90a9ba7 | 2026-06-10 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | fcf5044a-8cfd-47d5-9f47-8f6674843c24 | 2026-06-08 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Sun Pharmaceutical Industries, Inc. | 7ecd5eef-46f4-407f-9b63-ba65adb3eced | 2026-06-03 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Camber Pharmaceuticals, Inc. | a18f591b-587e-4769-8ac2-9cfba0b82526 | 2026-05-22 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | ASCLEMED USA INC. | c42b2cb2-8b45-488b-bf63-81909a1f06cb | 2026-05-19 | Warnings, Adverse reactions | OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 17772-121 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-121 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-121 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-121 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-122 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-122 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-122 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-122 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-123 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-123 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-123 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
| 17772-123 | OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79416 | SUPPL | 2024-08-16 |
| 79410 | SUPPL | 2024-08-16 |
| 79409 | SUPPL | 2024-08-16 |
| 75289 | SUPPL | 2023-08-25 |
| 75023 | SUPPL | 2023-08-09 |
| 57152 | SUPPL | 2019-01-09 |
| 56884 | SUPPL | 2018-12-20 |
| 32310 | SUPPL | 2015-12-08 |
| 19382 | SUPPL | 2015-12-08 |
| 24422 | ORIG | 2012-11-29 |
| 22898 | ORIG | 2012-11-29 |
| 32309 | ORIG | 2012-10-23 |
| 23497 | ORIG | 2012-10-22 |
| 19381 | ORIG | 2012-10-22 |
| 51533 | ORIG | 1900-01-01 |
| 51532 | ORIG | 1900-01-01 |
| 51531 | ORIG | 1900-01-01 |